Press release
Why is Diabetic Macular Edema Treatment witnessing Significant Demand in the Global Market During 2017 to 2025?
A sample of this report is available upon request @ https://www.persistencemarketresearch.com/samples/14344
The standard treatment for diabetic macular edema is control of blood sugar levels i.e. glycaemia along with the control of lipid levels and renal function. Diabetes Control and Complications Trial (DCCT) reported 2.3% reduction in the DME incidence in patients who receiver intensive management of glycaemia. Moreover, UK Prospective Diabetes Study (UKPDS) showed that exhaustive control of blood glucose levels in type 2 diabetes patients decreased the risk of DME by 25%. Laser therapy is being used as standard treatment for diabetic macular edema since1985.
Diabetic macular edema can be of two type viz. focal DME and diffuse DME. However, the treatment for both the types is same and involve laser therapy. For clinically significant diabetic macular edema focal laser treatment is used to treat leakage from microaneurysms. Variety of intravetiral injections for treatment of diabetic macular edema are available in the market and many are in development stage.
Some of the commercially available drugs for diabetic macular edema include Lucentis (Ranibizumab injection), Avastin (Bevacizumab injection/solution), Aristocort (Triamcinolone tablet) etc. Moreover, other pharmacological treatments such as intraviteral corticosteroids like fluocinolone acetonide, anti-VEGF drugs, and dexamethasone intraviteral implants are currently being evaluated in clinical trials.
Increasing prevalence of diabetes in the prime factor driving growth of global diabetic macular edema therapeutics market. The prevalence of diabetic macular edema is higher in type 2 diabetes patients than in type 1 diabetes patients. As per study conducted by University Hospital Sant Joan de Reus Spain, the incidence of diabetic macular edema is in the range of 0.9%-2.3%, annually, across the globe. Besides this, substantial R&D investment by pharmaceutical companies and advancement in ophthalmic surgrey techniques are some other factors fueling the growth of global diabetic macular edema treatment market.
The global market for diabetic macular edema treatment is segmented on basis of treatment type, end user and geography:
Segmentation by treatment
Laser Photocoagulation Therapy
Pharmacological Therapy
Bevacizumab
Ranibizumab
Triamcinolone
Segmentation by End User
Hospitals
Ophthalmic Clinics
Research Institutes
Contract Research Organizations
Based on treatment type, the diabetic macular edema market has been classified as laser photocoagulation therapy and pharmacological therapy (further classified as bevacizumab, ranibizumab and triamcinolone). Combination of pharmacological therapy after laser treatment is often recommended by the physicians. However, laser photocoagulation is expected to hold largest share in global diabetic macular edema treatment market.
Based on end user, the global diabetic macular edema market has been segmented into hospitals, ophthalmic clinics, research institutes and contract research organizations. Hospitals are expected to contribute highest share in the global diabetic macular edema treatment market over the forecast period.
On the basis of regional presence, global diabetic macular edema treatment market is segmented into five key regions viz. North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. North America is expected to lead the global market while Europe is expected to hold second largest market share in global diabetic macular edema treatment market. As per study results from University of Illinois, 2.8% of diabetic patients above age 40 years developed macular edema in the U.S. in 2012.
To view TOC of this report is available upon request @ https://www.persistencemarketresearch.com/toc/14344
Some of the players operating in global diabetic macular edema market are Genentech Inc. (a member of Roche group), Novartis Europharm Limited (Novartis AG), Stiefel Laboratories Inc., (GlaxoSmithKline Plc.), Eyetech Pharmaceuticals, Alimera Sciences and others.
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Why is Diabetic Macular Edema Treatment witnessing Significant Demand in the Global Market During 2017 to 2025? here
News-ID: 750201 • Views: …
More Releases from Persistence Market Research
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview:
The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period.
Market Size and Growth:
The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and…
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction
Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities.
Get Access To…
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview:
The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033.
The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an…
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products.
To obtain the latest market…
More Releases for Diabetic
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Expanding Diabetic Populace Driven Growth For Diabetic Food Market Globally
Market Overview
Diabetic Food items are dietary items that incorporate diminished starch and sugar substance that assistance in controlling the ascent of the blood glucose. Diabetic Food additionally contains low calorie sweeteners, slim down refreshments, and so on. These items are devoured by diabetic individuals and by the general population who are not diabetic as careful step to avoid diabetes. Diabetic nourishment makers are entering into different market fragments by presenting…
Global Diabetic Footwear Market Is Driven By Growing Diabetic Patients Worldwide
Global Diabetic Footwear Market Report, published by Variant Market Research, forecast that the global market is expected to reach $9.4 Billion by 2024 from $5.3 Billion in 2016; growing at a CAGR of 7.4% from 2016 to 2024.
To browse the complete report, visit at https://www.variantmarketresearch.com/report-categories/consumer-goods/diabetic-footwear-market
Diabetic footwears are used to reduce foot amputation and ulceration risk in people suffering from diabetes. It is a lifestyle disease. Foot ulceration and debilitating…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
